Designing a national combined reporting form for adverse drug reactions and medication errors;Élaboration d'un formulaire de notification national combinant les réactions indésirables aux medicaments et les erreurs de médication

Eastern Mediterranean Health Journal

Volumn 21, Issue 4, 2015, Pages 246-255

  Tanti, A ^a   Serracino Inglott, A ^a,b   Borg, J J ^a,c  

^a University of Malta ^*  (Malta)

^b UNIVERSITY OF MALTA   (Malta)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY CARE; DRUG LEGISLATION; DRUG SURVEILLANCE PROGRAM; EUROPEAN MEDICINES AGENCY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MEDICATION ERROR; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION; ADVERSE DRUG REACTION; MALTA; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MALTA; MEDICATION ERRORS; PROGRAM DEVELOPMENT;

EID: 84930514474     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2015.21.4.246     Document Type: Article

References (20)

1. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal L. 2004; 311:67–128 (as amended by Directive 2010/84/EU, consolidated version 2012).
2. Borg JJ, Aislaitner G, Pirozynski M, Mifsud S. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug Saf. 2011 Mar 1;34(3):187-97. PMID: 21332243
3. Legal notice 61 of 2006 of the Malta Government; Pharmacovigilance Regulations. The Malta Government Gazette. 2006;231:2981.
4. Reporting a medication or vaccine error or hazard to ISMP [Internet]. Horsham (PA): Institute for Safe Medication Practices (https://www.ismp.org/orderforms/reporterrortoismp.asp, accessed 19 February 2015).
5. Report medication errors [Internet]. Rockville (MD): National Coordinating Council for Medication Error Reporting and Prevention (http://www.nccmerp.org/report-medication-errors, accessed 19 February 2015).
6. Medication error (ME) report form [Internet]. Kuala Lumpur: Pharmaceutical Services Divisions of the Ministry of Health Malaysia (http://www.pharmacy.gov.my/v2/en/documents/ medication-error-me-report-form.html, accessed 19 February 2015).
7. Report a patient safety incident [Internet]. London: National Patient Safety Agency of the National Health Service (http://www.nrls.npsa.nhs.uk/report-a-patient-safety-incident/, accessed 19 February 2015).
8. U David. Medication error reporting systems: problems and solutions. New Medicine. 2001 November;1(2):61–5 (http://www.ismp-canada.org/download/Medication%20Error%20Reporting%20Systems%20-%20Problems%20and%20Solutions.pdf, accessed 19 February 2015).
9. Terzibanjana AR, Laaksonenb R, Weissb M, Airaksinena M, Wulijic T. Medication error reporting systems—lessons learnt. Executive summary of study of findings [Internet]. The Hague, The Netherlands: International Pharmaceutical Federation (http://www.fip.org/files/fip/Patient%20Safety/Medication%20Error%20Reporting%20-%20Lessons%20Learnt2008.pdf, accessed 19 February 2015).
10. Montesi G, Lechi A. Prevention of medication errors: detection and audit. Br J Clin Pharmacol. 2009 Jun;67(6):651–5. PMID:19594533
11. Tanti A, Camilleri M, Bonanno PV, Borg JJ Medication errors through a national pharmacovigilance database approach: a study for Malta. Int J Risk Saf Med. 2013;25(1):17–27. PMID:23442294
12. Anderson B, Fagerhaug T.: Root cause analysis: simplified tools and techniques. 2nd ed. Milwaukee (WI): ASQ Quality Press; 2006.
13. Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013 May;36(5):317–28. PMID:23640659
14. How to report adverse drug reactions (ADRs) [Internet]. Gzira, Malta: Medicines Authority (http://www.medicinesauthority.gov.mt/adrportal?l=1, accessed 19 February 2015).
15. Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag. 2005 Sep;1(3):181–8. PMID:18360558
16. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000 Aug;23(2):165–72. PMID:10945377
17. Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011 Oct;2(4):129–36. PMID:22145123
18. Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):217–22. PMID:20033911
19. Biagi C, Montanaro N, Buccellato E, Roberto G, Vaccheri A, Motola D. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). Eur J Clin Pharmacol. 2013 Feb;69(2):237–44. PMID:22706618
20. Edwards IR. Spontaneous reporting–of what? Clinical concerns about drugs. Br J Clin Pharmacol. 1999 Aug;48(2):138–41. PMID:10417488